Mechanistic Insights into Selective Autophagy Subtypes in Alzheimer’s Disease
Authors:
- Xinjie GuanXGXinjie Guan
- Ashok IyaswamyAIAshok Iyaswamy
- Sravan Gopalkrishnashetty SreenivasmurthySSSravan Gopalkrishnashetty Sreenivasmurthy
- Chengfu SuCSChengfu Su
- Zhou ZhuZZZhou Zhu
- Jia LiuJLJia Liu
- Yuxuan KanYKYuxuan Kan
- King-Ho CheungKCKing-Ho Cheung
- Jiahong LuJLJiahong Lu
- Jieqiong TanJTJieqiong Tan
- Min LiMLMin Li
Open Access
- 25 March 2022
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (7) , 3609
Abstract
Eukaryotic cells possess a plethora of regulatory mechanisms to maintain homeostasis and ensure proper biochemical functionality. Autophagy, a central, conserved self-consuming process of the cell, ensures the timely degradation of damaged cellular components. Several studies have demonstrated the important roles of autophagy activation in mitigating neurodegenerative diseases, especially Alzheimer’s disease (AD). However, surprisingly, activation of macroautophagy has not shown clinical efficacy. Hence, alternative strategies are urgently needed for AD therapy. In recent years, selective autophagy has been reported to be involved in AD pathology, and different subtypes have been identified, such as aggrephagy, mitophagy, reticulophagy, lipophagy, pexophagy, nucleophagy, lysophagy and ribophagy. By clarifying the underlying mechanisms governing these various subtypes, we may come to understand how to control autophagy to treat AD. In this review, we summarize the latest findings concerning the role of selective autophagy in the pathogenesis of AD. The evidence overwhelmingly suggests that selective autophagy is an active mechanism in AD pathology, and that regulating selective autophagy would be an effective strategy for controlling this pathogenesis.Keywords
Funding Information
- Science, Technology and Innovation Commission of Shenzhen Municipality (JCYJ20180507184656626, JCYJ20180302174028790)
This publication has 241 references indexed in Scilit:
- Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer's disease: Implications to mitochondria-targeted antioxidant therapeuticsBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2012
- SnapShot: Mitochondrial Quality ControlCell, 2011
- Depletion of Beclin-1 due to proteolytic cleavage by caspases in the Alzheimer's disease brainNeurobiology of Disease, 2011
- Proteasome Inhibition Drives HDAC6-Dependent Recruitment of Tau to AggresomesJournal of Molecular Neuroscience, 2011
- Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and Alzheimer's diseaseThe Lancet Neurology, 2011
- Mitochondrial permeability transition pore in Alzheimer's disease: Cyclophilin D and amyloid betaBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2010
- PINK1-Associated Parkinson's Disease Is Caused by Neuronal Vulnerability to Calcium-Induced Cell DeathMolecular Cell, 2009
- Mitochondria in Neuroplasticity and Neurological DisordersNeuron, 2008
- Amyloid Precursor Protein Regulates Brain Apolipoprotein E and Cholesterol Metabolism through Lipoprotein Receptor LRP1Neuron, 2007
- Alzheimer's Disease and Mild Cognitive ImpairmentNeurologic Clinics, 2007